| NCT03826056 |
Neurology Inpatient Clinical Education Trial |
https://ClinicalTrials.gov/show/NCT03826056 |
Active, not recruiting |
Dartmouth-Hitchcock Medical Center |
2020-10-31 |
| NCT03317093 |
Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF Device |
https://ClinicalTrials.gov/show/NCT03317093 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2020-03-31 |
| NCT03295318 |
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds |
https://ClinicalTrials.gov/show/NCT03295318 |
Completed |
Serum Institute of India Pvt. Ltd. |
2018-08-31 |
| NCT03205371 |
Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers |
https://ClinicalTrials.gov/show/NCT03205371 |
Completed |
Sanofi |
2018-07-19 |
| NCT03205358 |
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT03205358 |
Completed |
Sanofi |
2015-08-19 |
| NCT03112031 |
Treatment With Tamoxifen in Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT03112031 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2018-07-17 |
| NCT03100786 |
Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis |
https://ClinicalTrials.gov/show/NCT03100786 |
Recruiting |
Oxford University Clinical Research Unit, Vietnam |
2021-12-01 |
| NCT03092817 |
Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial) |
https://ClinicalTrials.gov/show/NCT03092817 |
Recruiting |
Oxford University Clinical Research Unit, Vietnam |
2021-04-01 |
| NCT03077438 |
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years |
https://ClinicalTrials.gov/show/NCT03077438 |
Completed |
Sanofi |
2017-10-10 |
| NCT02972281 |
Systematic Search for Primary Immunodeficiency in Adults With Infections |
https://ClinicalTrials.gov/show/NCT02972281 |
Recruiting |
University Hospital, Lille |
2020-03-31 |
| NCT02955797 |
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers |
https://ClinicalTrials.gov/show/NCT02955797 |
Completed |
Sanofi |
2017-10-26 |
| NCT02910037 |
Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort |
https://ClinicalTrials.gov/show/NCT02910037 |
Completed |
University of California, San Francisco |
2017-07-31 |
| NCT02881957 |
Hypovitaminosis D in Neurocritical Patients |
https://ClinicalTrials.gov/show/NCT02881957 |
Completed |
University of Utah |
2018-10-10 |
| NCT02858570 |
Conjugate Vaccine Against Meningococcus C a Brazilian Project |
https://ClinicalTrials.gov/show/NCT02858570 |
Recruiting |
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) |
2019-05-31 |
| NCT02842866 |
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older |
https://ClinicalTrials.gov/show/NCT02842866 |
Completed |
Sanofi |
2017-02-13 |
| NCT02842853 |
Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT02842853 |
Completed |
Sanofi |
2017-02-28 |
| NCT02806284 |
Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery |
https://ClinicalTrials.gov/show/NCT02806284 |
Completed |
Uppsala University |
2008-01-31 |
| NCT02752906 |
Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT02752906 |
Completed |
Sanofi |
2016-12-19 |
| NCT02724046 |
Ciprofloxacin for the Prevention of Meningococcal Meningitis |
https://ClinicalTrials.gov/show/NCT02724046 |
Completed |
Epicentre |
2017-05-30 |
| NCT02640404 |
Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam |
https://ClinicalTrials.gov/show/NCT02640404 |
Completed |
Sanofi |
2016-12-05 |
| NCT01373710 |
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis |
https://ClinicalTrials.gov/show/NCT01373710 |
Completed |
Institut Curie |
2018-04-30 |
| NCT02633787 |
Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier |
https://ClinicalTrials.gov/show/NCT02633787 |
Completed |
Sanofi |
2016-02-29 |
| NCT02591290 |
Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT02591290 |
Completed |
Sanofi |
2016-03-16 |
| NCT02531698 |
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years |
https://ClinicalTrials.gov/show/NCT02531698 |
Completed |
Pfizer |
2017-03-31 |
| NCT02526394 |
Pertussis and Meningitis C Concomitant Vaccination in Adolescents |
https://ClinicalTrials.gov/show/NCT02526394 |
Completed |
Public Health England |
2017-03-31 |
| NCT02398396 |
Investigating Meningococcal Vaccines in Adults |
https://ClinicalTrials.gov/show/NCT02398396 |
Active, not recruiting |
University of Oxford |
2015-11-30 |
| NCT01580033 |
Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT01580033 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2012-09-30 |
| NCT02305446 |
Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. |
https://ClinicalTrials.gov/show/NCT02305446 |
Completed |
Novartis |
2015-04-30 |
| NCT02274285 |
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants |
https://ClinicalTrials.gov/show/NCT02274285 |
Completed |
Sanofi |
2016-05-28 |
| NCT02237365 |
A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis |
https://ClinicalTrials.gov/show/NCT02237365 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2016-06-24 |
| NCT02199691 |
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents |
https://ClinicalTrials.gov/show/NCT02199691 |
Completed |
Sanofi |
2015-10-02 |
| NCT02169882 |
High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study |
https://ClinicalTrials.gov/show/NCT02169882 |
Completed |
Universitas Padjadjaran |
2016-11-05 |
| NCT02139228 |
Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children |
https://ClinicalTrials.gov/show/NCT02139228 |
Completed |
Novartis |
2014-12-31 |
| NCT02102256 |
A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients |
https://ClinicalTrials.gov/show/NCT02102256 |
Active, not recruiting |
University of Southern California |
2019-01-31 |
| NCT02080559 |
Investigating the Immune Response to 4CMenB in Infants |
https://ClinicalTrials.gov/show/NCT02080559 |
Completed |
University of Oxford |
2016-06-30 |
| NCT01274897 |
A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea |
https://ClinicalTrials.gov/show/NCT01274897 |
Completed |
Novartis |
2011-03-31 |
| NCT01270503 |
Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines |
https://ClinicalTrials.gov/show/NCT01270503 |
Completed |
Sanofi |
2013-12-31 |
| NCT02054091 |
Feeding Bovine Colostrum to Preterm Infants |
https://ClinicalTrials.gov/show/NCT02054091 |
Completed |
Rigshospitalet, Denmark |
2016-12-31 |
| NCT02003495 |
Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT02003495 |
Completed |
Beijing Minhai Biotechnology Co., Ltd |
2014-08-31 |
| NCT02003313 |
Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine |
https://ClinicalTrials.gov/show/NCT02003313 |
Completed |
Beijing Minhai Biotechnology Co., Ltd |
2015-05-31 |
| NCT01904448 |
Auditory Brainstem Implantation in Young Children |
https://ClinicalTrials.gov/show/NCT01904448 |
Completed |
University of North Carolina, Chapel Hill |
2017-10-01 |
| NCT01897402 |
Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT01897402 |
Completed |
JN-International Medical Corporation |
2014-05-31 |
| NCT01894919 |
Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28 |
https://ClinicalTrials.gov/show/NCT01894919 |
Completed |
Novartis |
2015-09-30 |
| NCT01890759 |
Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation |
https://ClinicalTrials.gov/show/NCT01890759 |
Completed |
Sanofi |
2016-04-12 |
| NCT01889836 |
Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos |
https://ClinicalTrials.gov/show/NCT01889836 |
Completed |
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) |
2014-12-31 |
| NCT01802502 |
Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation |
https://ClinicalTrials.gov/show/NCT01802502 |
Completed |
Universitas Padjadjaran |
2013-10-31 |
| NCT01802385 |
Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT01802385 |
Completed |
University of Minnesota |
2017-09-30 |
| NCT01745679 |
Pharmacological Study of High Doses of Ceftriaxone in Meningitidis |
https://ClinicalTrials.gov/show/NCT01745679 |
Completed |
Nantes University Hospital |
2015-12-31 |
| NCT01732627 |
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older |
https://ClinicalTrials.gov/show/NCT01732627 |
Completed |
Sanofi |
2013-01-17 |
| NCT01719510 |
Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis |
https://ClinicalTrials.gov/show/NCT01719510 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-06-03 |
| NCT01717638 |
Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1 |
https://ClinicalTrials.gov/show/NCT01717638 |
Completed |
Novartis |
2013-09-30 |
| NCT01661751 |
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003 |
https://ClinicalTrials.gov/show/NCT01661751 |
Completed |
Hualan Biological Engineering, Inc. |
2006-05-31 |
| NCT01661738 |
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002 |
https://ClinicalTrials.gov/show/NCT01661738 |
Completed |
Hualan Biological Engineering, Inc. |
2006-05-31 |
| NCT01661725 |
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001 |
https://ClinicalTrials.gov/show/NCT01661725 |
Completed |
Hualan Biological Engineering, Inc. |
2006-04-30 |
| NCT01659996 |
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age |
https://ClinicalTrials.gov/show/NCT01659996 |
Completed |
Sanofi |
2014-11-30 |
| NCT01642589 |
Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea |
https://ClinicalTrials.gov/show/NCT01642589 |
Completed |
Sanofi |
2013-01-31 |
| NCT01593514 |
Understanding the Immune Response to Two Different Meningitis Vaccines |
https://ClinicalTrials.gov/show/NCT01593514 |
Completed |
University of Oxford |
2013-04-30 |
| NCT01589289 |
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC |
https://ClinicalTrials.gov/show/NCT01589289 |
Completed |
Institute of Tropical Medicine, Belgium |
2015-01-31 |
| NCT01554124 |
Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis |
https://ClinicalTrials.gov/show/NCT01554124 |
Completed |
PENTA Foundation |
2014-12-31 |
| NCT01547715 |
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India |
https://ClinicalTrials.gov/show/NCT01547715 |
Completed |
Novartis |
2014-04-30 |
| NCT01543087 |
Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose |
https://ClinicalTrials.gov/show/NCT01543087 |
Completed |
Pfizer |
2018-01-05 |
| NCT01540838 |
Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis |
https://ClinicalTrials.gov/show/NCT01540838 |
Completed |
University of Helsinki |
2017-02-28 |
| NCT01535469 |
Operational Research for Cryptococcal Antigen Screening |
https://ClinicalTrials.gov/show/NCT01535469 |
Completed |
University of Minnesota |
2015-06-30 |
| NCT01519713 |
Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT01519713 |
Completed |
Sanofi |
2012-09-30 |
| NCT01482052 |
Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis |
https://ClinicalTrials.gov/show/NCT01482052 |
Completed |
JN-International Medical Corporation |
2013-01-31 |
| NCT01478347 |
A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults |
https://ClinicalTrials.gov/show/NCT01478347 |
Completed |
Novartis |
2014-03-31 |
| NCT02024282 |
Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care |
https://ClinicalTrials.gov/show/NCT02024282 |
Completed |
KU Leuven |
2014-12-31 |
| NCT01466387 |
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults |
https://ClinicalTrials.gov/show/NCT01466387 |
Completed |
Novartis |
2012-04-30 |
| NCT01453348 |
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT01453348 |
Completed |
Novartis |
2012-01-31 |
| NCT01443416 |
An Alternative Booster Vaccine Against Meningitis and Ear Infections |
https://ClinicalTrials.gov/show/NCT01443416 |
Completed |
University of Oxford |
2013-08-31 |
| NCT01442675 |
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine |
https://ClinicalTrials.gov/show/NCT01442675 |
Completed |
Sanofi |
2012-06-30 |
| NCT01434680 |
Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT01434680 |
Completed |
Novartis |
2012-11-30 |
| NCT01430611 |
Study of Sanofi Pasteur and Lanzhou Institute’s Meningococcal (Group A and C) Polysaccharide Vaccine in Children |
https://ClinicalTrials.gov/show/NCT01430611 |
Completed |
Sanofi |
2012-08-31 |
| NCT01428908 |
Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children |
https://ClinicalTrials.gov/show/NCT01428908 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2011-12-31 |
| NCT01424644 |
A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents |
https://ClinicalTrials.gov/show/NCT01424644 |
Completed |
Novartis |
2012-12-31 |
| NCT01423084 |
Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years |
https://ClinicalTrials.gov/show/NCT01423084 |
Completed |
Novartis |
2011-12-31 |
| NCT01410474 |
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan |
https://ClinicalTrials.gov/show/NCT01410474 |
Completed |
Novartis |
2012-01-31 |
| NCT01367158 |
Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines |
https://ClinicalTrials.gov/show/NCT01367158 |
Completed |
Novartis |
2012-01-31 |
| NCT01359449 |
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations |
https://ClinicalTrials.gov/show/NCT01359449 |
Completed |
Sanofi |
2012-07-31 |
| NCT01352793 |
A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years |
https://ClinicalTrials.gov/show/NCT01352793 |
Completed |
Pfizer |
2014-09-30 |
| NCT01340898 |
Immunogenicity and Safety Study of GSK Biologicals’ Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT01340898 |
Completed |
GlaxoSmithKline |
2014-08-04 |
| NCT01339923 |
A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years |
https://ClinicalTrials.gov/show/NCT01339923 |
Completed |
Novartis |
2014-01-31 |
| NCT01323270 |
A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. |
https://ClinicalTrials.gov/show/NCT01323270 |
Completed |
Pfizer |
2012-10-31 |
| NCT04368429 |
Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age |
https://ClinicalTrials.gov/show/NCT04368429 |
Recruiting |
Sanofi |
2020-12-31 |
| NCT04325685 |
The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04325685 |
Active, not recruiting |
Northern State Medical University |
2021-12-31 |
| NCT04236960 |
Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population. |
https://ClinicalTrials.gov/show/NCT04236960 |
Completed |
Walvax Biotechnology Co., Ltd. |
2019-09-16 |
| NCT04142242 |
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49 |
https://ClinicalTrials.gov/show/NCT04142242 |
Recruiting |
Sanofi |
2020-02-14 |
| NCT00297687 |
Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00297687 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT04135053 |
A Controlled Study to Assess Safety, Colonisation and Immunogenicity of Reconstituted Lyophilised Neisseria Lactamica |
https://ClinicalTrials.gov/show/NCT04135053 |
Recruiting |
University of Southampton |
2020-02-01 |
| NCT04084769 |
Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine,in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4) |
https://ClinicalTrials.gov/show/NCT04084769 |
Active, not recruiting |
Sanofi |
2020-10-31 |
| NCT04080921 |
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis |
https://ClinicalTrials.gov/show/NCT04080921 |
Completed |
Vinmec Research Institute of Stem Cell and Gene Technology |
2019-06-30 |
| NCT04031833 |
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) |
https://ClinicalTrials.gov/show/NCT04031833 |
Recruiting |
Matinas BioPharma Nanotechnologies, Inc. |
2021-04-30 |
| NCT03964012 |
Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5) |
https://ClinicalTrials.gov/show/NCT03964012 |
Active, not recruiting |
Serum Institute of India Pvt. Ltd. |
2020-02-23 |
| NCT03945448 |
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia |
https://ClinicalTrials.gov/show/NCT03945448 |
Recruiting |
Makerere University |
2023-05-31 |
| NCT03891758 |
Confirmatory Study of BK1310 in Healthy Infants |
https://ClinicalTrials.gov/show/NCT03891758 |
Active, not recruiting |
Mitsubishi Tanabe Pharma Corporation |
2019-09-18 |
| NCT03890367 |
Study of a Quadrivalent Meningococcal Conjugate Vaccine Compared With Two Meningococcal Reference Vaccines in Europeans Toddlers |
https://ClinicalTrials.gov/show/NCT03890367 |
Recruiting |
Sanofi |
2020-10-31 |
| NCT03787940 |
Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis |
https://ClinicalTrials.gov/show/NCT03787940 |
Recruiting |
Beijing Chest Hospital |
2021-12-31 |
| NCT03746665 |
Maternal Immunization With MenAfriVacâ„¢ |
https://ClinicalTrials.gov/show/NCT03746665 |
Recruiting |
London School of Hygiene and Tropical Medicine |
2020-06-30 |
| NCT03682939 |
Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population |
https://ClinicalTrials.gov/show/NCT03682939 |
Recruiting |
St George’s, University of London |
2020-06-30 |
| NCT03673462 |
Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT03673462 |
Recruiting |
Sanofi |
2023-03-31 |
| NCT03633474 |
Defining the Immune Response to Nasopharyngeal Colonisation by the Commensal Neisseria Lactamica |
https://ClinicalTrials.gov/show/NCT03633474 |
Completed |
University of Southampton |
2019-09-01 |
| NCT03632720 |
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom |
https://ClinicalTrials.gov/show/NCT03632720 |
Recruiting |
Sanofi |
2022-06-30 |
| NCT03630705 |
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico |
https://ClinicalTrials.gov/show/NCT03630705 |
Recruiting |
Sanofi |
2022-12-31 |
| NCT03630250 |
Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA) |
https://ClinicalTrials.gov/show/NCT03630250 |
Completed |
University of Southampton |
2019-09-01 |
| NCT03587207 |
Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals’ MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years |
https://ClinicalTrials.gov/show/NCT03587207 |
Completed |
GlaxoSmithKline |
2018-12-19 |
| NCT03549325 |
A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14 |
https://ClinicalTrials.gov/show/NCT03549325 |
Recruiting |
University Hospital Southampton NHS Foundation Trust |
2020-02-29 |
| NCT03547271 |
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe |
https://ClinicalTrials.gov/show/NCT03547271 |
Recruiting |
Sanofi |
2023-08-31 |
| NCT03537508 |
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US |
https://ClinicalTrials.gov/show/NCT03537508 |
Recruiting |
Sanofi |
2022-12-31 |
| NCT03493919 |
A Sourcing Study to Collect Human Blood Samples From Healthy Adults |
https://ClinicalTrials.gov/show/NCT03493919 |
Recruiting |
GlaxoSmithKline |
2023-09-22 |
| NCT03480191 |
Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis |
https://ClinicalTrials.gov/show/NCT03480191 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2021-06-30 |
| NCT03476135 |
Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children |
https://ClinicalTrials.gov/show/NCT03476135 |
Completed |
Sanofi |
2018-09-10 |
| NCT03421002 |
Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis |
https://ClinicalTrials.gov/show/NCT03421002 |
Completed |
Astellas Pharma Inc |
2018-04-10 |
| NCT01247909 |
Infant Severe Sepsis and Bacterial Meningitis in Malawi |
https://ClinicalTrials.gov/show/NCT01247909 |
Completed |
University of Malawi College of Medicine |
2015-02-28 |
| NCT01239043 |
Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination |
https://ClinicalTrials.gov/show/NCT01239043 |
Completed |
Sanofi |
2011-04-30 |
| NCT01214837 |
Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life |
https://ClinicalTrials.gov/show/NCT01214837 |
Completed |
Novartis |
2012-04-30 |
| NCT01210885 |
Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents |
https://ClinicalTrials.gov/show/NCT01210885 |
Completed |
Novartis |
2011-07-31 |
| NCT01192997 |
Comparison of Two Meningococcal ACWY Conjugate Vaccines |
https://ClinicalTrials.gov/show/NCT01192997 |
Completed |
Public Health England |
2013-10-31 |
| NCT01158755 |
Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study |
https://ClinicalTrials.gov/show/NCT01158755 |
Completed |
Universitas Padjadjaran |
2011-12-31 |
| NCT01148017 |
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT01148017 |
Completed |
Novartis |
2013-04-30 |
| NCT01119482 |
Study on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal Carriage |
https://ClinicalTrials.gov/show/NCT01119482 |
Completed |
London School of Hygiene and Tropical Medicine |
2012-05-31 |
| NCT01148524 |
Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 |
https://ClinicalTrials.gov/show/NCT01148524 |
Completed |
Novartis |
2012-01-31 |
| NCT01086969 |
A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India |
https://ClinicalTrials.gov/show/NCT01086969 |
Completed |
Sanofi |
2011-02-28 |
| NCT01075152 |
Cryptococcal Optimal ART Timing Trial |
https://ClinicalTrials.gov/show/NCT01075152 |
Completed |
University of Minnesota |
2012-10-31 |
| NCT01049035 |
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT01049035 |
Completed |
Sanofi |
2012-02-13 |
| NCT01018732 |
A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY |
https://ClinicalTrials.gov/show/NCT01018732 |
Completed |
Novartis |
2010-07-31 |
| NCT00994695 |
Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine |
https://ClinicalTrials.gov/show/NCT00994695 |
Completed |
Armauer Hansen Research Institute, Ethiopia |
2006-01-31 |
| NCT00976040 |
Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00976040 |
Completed |
Botswana-UPenn Partnership |
2011-11-30 |
| NCT00962624 |
Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00962624 |
Completed |
Public Health England |
2011-03-31 |
| NCT00944034 |
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12 |
https://ClinicalTrials.gov/show/NCT00944034 |
Completed |
Novartis |
2011-08-31 |
| NCT00937521 |
Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants |
https://ClinicalTrials.gov/show/NCT00937521 |
Completed |
Novartis |
2010-11-30 |
| NCT00924820 |
A Pilot Study of Bevacizumab for Neoplastic Meningitis |
https://ClinicalTrials.gov/show/NCT00924820 |
Completed |
M.D. Anderson Cancer Center |
2015-09-30 |
| NCT00901940 |
Understanding the Immune Response to Meningitis Vaccines |
https://ClinicalTrials.gov/show/NCT00901940 |
Completed |
University of Oxford |
2010-10-31 |
| NCT00885703 |
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals |
https://ClinicalTrials.gov/show/NCT00885703 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-01-12 |
| NCT00879814 |
Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults |
https://ClinicalTrials.gov/show/NCT00879814 |
Completed |
Pfizer |
2012-07-31 |
| NCT00874549 |
Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years |
https://ClinicalTrials.gov/show/NCT00874549 |
Completed |
Sanofi |
2008-01-31 |
| NCT00856297 |
Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00856297 |
Completed |
Novartis |
2012-11-30 |
| NCT00854867 |
Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. |
https://ClinicalTrials.gov/show/NCT00854867 |
Completed |
Mundipharma Research Limited |
2012-10-31 |
| NCT00850603 |
Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® |
https://ClinicalTrials.gov/show/NCT00850603 |
Completed |
Sanofi |
2003-05-31 |
| NCT03824093 |
High and Low Resource Interventions to Promote HPV Vaccines |
https://ClinicalTrials.gov/show/NCT03824093 |
Enrolling by invitation |
Children’s Mercy Hospital Kansas City |
2019-12-31 |
| NCT00830856 |
Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa |
https://ClinicalTrials.gov/show/NCT00830856 |
Completed |
University of Zimbabwe |
2008-10-31 |
| NCT02955862 |
Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report |
https://ClinicalTrials.gov/show/NCT02955862 |
Completed |
National Hospital for Tropical Diseases, Hanoi, Vietnam |
2017-09-30 |
| NCT00808028 |
A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents |
https://ClinicalTrials.gov/show/NCT00808028 |
Completed |
Pfizer |
2014-03-31 |
| NCT01768117 |
Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age |
https://ClinicalTrials.gov/show/NCT01768117 |
Completed |
Pfizer |
2014-02-28 |
| NCT03927313 |
Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM |
https://ClinicalTrials.gov/show/NCT03927313 |
Recruiting |
University of Cape Town |
2020-06-30 |
| NCT00806195 |
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants |
https://ClinicalTrials.gov/show/NCT00806195 |
Completed |
Novartis |
2011-03-31 |
| NCT02943902 |
Reduced PCV Dosing Schedules in South African Infants |
https://ClinicalTrials.gov/show/NCT02943902 |
Completed |
University of Witwatersrand, South Africa |
2019-02-26 |
| NCT02864927 |
Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea |
https://ClinicalTrials.gov/show/NCT02864927 |
Completed |
Sanofi |
2019-06-12 |
| NCT03433482 |
A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals’ Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age |
https://ClinicalTrials.gov/show/NCT03433482 |
Completed |
GlaxoSmithKline |
2019-07-26 |
| NCT01633294 |
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term |
https://ClinicalTrials.gov/show/NCT01633294 |
Completed |
Hospital de Santa Maria, Portugal |
2011-01-31 |
| NCT03691610 |
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT03691610 |
Recruiting |
Sanofi |
2024-05-31 |
| NCT00777790 |
Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents |
https://ClinicalTrials.gov/show/NCT00777790 |
Completed |
Sanofi |
2004-04-30 |
| NCT00777257 |
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine |
https://ClinicalTrials.gov/show/NCT00777257 |
Completed |
Sanofi |
2007-03-31 |
| NCT00774384 |
Regulation of Mucosal Immune Response to Systemic MenB Vaccine |
https://ClinicalTrials.gov/show/NCT00774384 |
Completed |
University Hospitals Bristol NHS Foundation Trust |
2011-11-30 |
| NCT00772070 |
Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00772070 |
Completed |
Sanofi |
2003-08-31 |
| NCT00771849 |
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children |
https://ClinicalTrials.gov/show/NCT00771849 |
Completed |
Sanofi |
2004-03-31 |
| NCT00721396 |
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules |
https://ClinicalTrials.gov/show/NCT00721396 |
Completed |
Novartis |
2010-07-31 |
| NCT00715234 |
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients |
https://ClinicalTrials.gov/show/NCT00715234 |
Completed |
University of Colorado, Denver |
2009-12-31 |
| NCT00707785 |
Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis |
https://ClinicalTrials.gov/show/NCT00707785 |
Completed |
Johns Hopkins University |
2011-04-30 |
| NCT00700713 |
Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26 |
https://ClinicalTrials.gov/show/NCT00700713 |
Completed |
Sanofi |
2009-02-28 |
| NCT00700635 |
Dose Comparison Study of Menactra® in US Children |
https://ClinicalTrials.gov/show/NCT00700635 |
Completed |
Sanofi |
2009-05-31 |
| NCT00678652 |
Phase 1 Safety and Immunogenicity of Meningococcal Vaccine |
https://ClinicalTrials.gov/show/NCT00678652 |
Completed |
U.S. Army Medical Research and Development Command |
2009-08-31 |
| NCT00674674 |
Phase 1 Intrathecal Topotecan for Neoplastic Meningitis |
https://ClinicalTrials.gov/show/NCT00674674 |
Completed |
Baylor College of Medicine |
2010-08-31 |
| NCT00667602 |
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT00667602 |
Completed |
Novartis |
2009-07-31 |
| NCT00657709 |
Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants |
https://ClinicalTrials.gov/show/NCT00657709 |
Completed |
Novartis |
2010-01-31 |
| NCT00643916 |
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age |
https://ClinicalTrials.gov/show/NCT00643916 |
Completed |
Sanofi |
2006-03-31 |
| NCT00631995 |
Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers |
https://ClinicalTrials.gov/show/NCT00631995 |
Completed |
Sanofi |
2009-02-28 |
| NCT00626327 |
Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT00626327 |
Completed |
Novartis |
2010-07-31 |
| NCT00625677 |
Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life |
https://ClinicalTrials.gov/show/NCT00625677 |
Completed |
Public Health England |
2010-03-31 |
| NCT00619203 |
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis |
https://ClinicalTrials.gov/show/NCT00619203 |
Completed |
University of Malawi College of Medicine |
2012-03-31 |
| NCT00617760 |
Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) |
https://ClinicalTrials.gov/show/NCT00617760 |
Completed |
Pfizer |
2009-08-31 |
| NCT00616421 |
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children |
https://ClinicalTrials.gov/show/NCT00616421 |
Completed |
Novartis |
2009-04-30 |
| NCT00539032 |
Immunology and Safety of Menactra® in Children in Saudi Arabia |
https://ClinicalTrials.gov/show/NCT00539032 |
Completed |
Sanofi |
2008-08-31 |
| NCT00518180 |
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents |
https://ClinicalTrials.gov/show/NCT00518180 |
Completed |
Novartis |
2008-04-30 |
| NCT00495690 |
Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease |
https://ClinicalTrials.gov/show/NCT00495690 |
Completed |
Society for Applied Studies |
2007-11-30 |
| NCT00483574 |
Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT00483574 |
Completed |
Sanofi |
2009-01-31 |
| NCT00474526 |
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants |
https://ClinicalTrials.gov/show/NCT00474526 |
Completed |
Novartis |
2008-09-30 |
| NCT00474487 |
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults |
https://ClinicalTrials.gov/show/NCT00474487 |
Completed |
Novartis |
2007-08-31 |
| NCT00459316 |
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth |
https://ClinicalTrials.gov/show/NCT00459316 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-03-31 |
| NCT00450437 |
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults |
https://ClinicalTrials.gov/show/NCT00450437 |
Completed |
Novartis |
2007-08-31 |
| NCT00444951 |
Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia |
https://ClinicalTrials.gov/show/NCT00444951 |
Completed |
Sanofi |
2008-02-29 |
| NCT00443846 |
RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) |
https://ClinicalTrials.gov/show/NCT00443846 |
Completed |
Merck Sharp & Dohme Corp. |
2007-09-04 |
| NCT00427076 |
Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections |
https://ClinicalTrials.gov/show/NCT00427076 |
Completed |
Rabin Medical Center |
2014-05-31 |
| NCT00422292 |
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT00422292 |
Completed |
Sanofi |
2009-01-31 |
| NCT00392808 |
Immunogenicity of the Booster Dose of Two MenC Vaccines |
https://ClinicalTrials.gov/show/NCT00392808 |
Completed |
Centro Superior de Investigación en Salud Publica |
2008-05-31 |
| NCT00384397 |
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT00384397 |
Completed |
Sanofi |
2008-08-31 |
| NCT00372515 |
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations |
https://ClinicalTrials.gov/show/NCT00372515 |
Completed |
Dana-Farber Cancer Institute |
2012-12-31 |
| NCT00371878 |
Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection |
https://ClinicalTrials.gov/show/NCT00371878 |
Completed |
Royal Liverpool University Hospital |
NA |
| NCT00355121 |
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® |
https://ClinicalTrials.gov/show/NCT00355121 |
Completed |
Sanofi |
2009-06-30 |
| NCT00329901 |
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years |
https://ClinicalTrials.gov/show/NCT00329901 |
Completed |
Novartis |
2007-05-31 |
| NCT00325130 |
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) |
https://ClinicalTrials.gov/show/NCT00325130 |
Completed |
Merck Sharp & Dohme Corp. |
2007-04-30 |
| NCT00316654 |
Persistence of Antibody Response to N. Meningitidis Group C in Children |
https://ClinicalTrials.gov/show/NCT00316654 |
Completed |
Novartis |
2005-10-31 |
| NCT00314041 |
Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants |
https://ClinicalTrials.gov/show/NCT00314041 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
1998-04-30 |
| NCT00311415 |
Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children |
https://ClinicalTrials.gov/show/NCT00311415 |
Completed |
Novartis |
2008-04-30 |
| NCT00310856 |
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) |
https://ClinicalTrials.gov/show/NCT00310856 |
Completed |
Novartis |
2006-11-30 |
| NCT00310817 |
Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months. |
https://ClinicalTrials.gov/show/NCT00310817 |
Completed |
Novartis |
2006-05-31 |
| NCT00310713 |
Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine |
https://ClinicalTrials.gov/show/NCT00310713 |
Completed |
Novartis |
2006-08-31 |
| NCT00310700 |
Kinetics of B Cell Response in Infants Menjugate Vaccination |
https://ClinicalTrials.gov/show/NCT00310700 |
Completed |
Novartis |
2005-11-30 |
| NCT00310687 |
Persistence of Immune Response After Vaccination With MCC |
https://ClinicalTrials.gov/show/NCT00310687 |
Completed |
Novartis |
2005-12-31 |
| NCT00310674 |
Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age |
https://ClinicalTrials.gov/show/NCT00310674 |
Completed |
Novartis |
NA |
| NCT00310635 |
Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age |
https://ClinicalTrials.gov/show/NCT00310635 |
Completed |
Novartis |
NA |
| NCT00271479 |
Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine |
https://ClinicalTrials.gov/show/NCT00271479 |
Completed |
Epicentre |
NA |
| NCT00269477 |
Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune® |
https://ClinicalTrials.gov/show/NCT00269477 |
Completed |
Sanofi |
2007-02-28 |
| NCT00258856 |
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune® |
https://ClinicalTrials.gov/show/NCT00258856 |
Completed |
Sanofi |
2007-03-31 |
| NCT00248833 |
Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. |
https://ClinicalTrials.gov/show/NCT00248833 |
Completed |
U.S. Army Medical Research and Development Command |
2006-11-30 |
| NCT00219401 |
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea |
https://ClinicalTrials.gov/show/NCT00219401 |
Completed |
Papua New Guinea Institute of Medical Research |
2009-05-31 |
| NCT00197808 |
Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines |
https://ClinicalTrials.gov/show/NCT00197808 |
Completed |
Public Health England |
2010-01-31 |
| NCT00161928 |
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants |
https://ClinicalTrials.gov/show/NCT00161928 |
Completed |
Pfizer |
NA |
| NCT00145249 |
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis |
https://ClinicalTrials.gov/show/NCT00145249 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-04-30 |
| NCT00119080 |
Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage |
https://ClinicalTrials.gov/show/NCT00119080 |
Completed |
Centers for Disease Control and Prevention |
NA |
| NCT00002750 |
Melphalan in Patients With Neoplastic Meningitis |
https://ClinicalTrials.gov/show/NCT00002750 |
Completed |
Duke University |
2001-05-31 |
| NCT00002306 |
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B |
https://ClinicalTrials.gov/show/NCT00002306 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00029523 |
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor |
https://ClinicalTrials.gov/show/NCT00029523 |
Completed |
Pacira Pharmaceuticals, Inc |
NA |
| NCT00780806 |
Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults |
https://ClinicalTrials.gov/show/NCT00780806 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2010-05-31 |
| NCT00012467 |
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00012467 |
Completed |
InterMune |
NA |
| NCT00002316 |
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002316 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002305 |
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002305 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002294 |
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002294 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002113 |
A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis. |
https://ClinicalTrials.gov/show/NCT00002113 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002077 |
An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002077 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002076 |
Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002076 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002075 |
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002075 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002074 |
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002074 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002068 |
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002068 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002040 |
Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00002040 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002019 |
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002019 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002010 |
Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis |
https://ClinicalTrials.gov/show/NCT00002010 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001017 |
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00001017 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1991-07-31 |
| NCT00000776 |
Dexamethasone in Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00000776 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000708 |
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00000708 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1991-07-31 |
| NCT00000677 |
SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy |
https://ClinicalTrials.gov/show/NCT00000677 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000639 |
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis |
https://ClinicalTrials.gov/show/NCT00000639 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |